*ST苏吴: 江苏吴中医药发展股份有限公司2025年第一次临时股东大会会议文件

Core Viewpoint - Jiangsu Wuzhong Pharmaceutical Development Co., Ltd. is holding its first extraordinary general meeting of shareholders in 2025 to discuss key proposals including the completion of fundraising projects and the election of independent directors [1][2]. Group 1: Meeting Agenda - The meeting is scheduled for July 14, 2025, at 14:30, lasting half a day, at the company's conference room in Suzhou, Jiangsu Province [1]. - The agenda includes the announcement of the meeting's start, attendance verification, discussion of various proposals, shareholder speeches, voting, announcement of results, legal opinions, and conclusion of the meeting [3]. Group 2: Proposals - Proposal One: The company plans to conclude the fundraising project for the generic drugs Linezolid and Voriconazole, reallocating the remaining funds to permanently supplement working capital for daily operations and business development, enhancing the efficiency of fund usage and benefiting all shareholders [2]. - Proposal Two: The company proposes to elect new independent directors to replace resigning members, with candidates including Sheng Hui and Pan Xiaolin, who will also take on roles in the audit and nomination committees [2][4].